Once-weekly semaglutide use in patients with type 2 diabetes: real-world data from the SURE Italy observational study.
Raffaele NapoliCesare BerraAndrei-Mircea CatarigChiara Di LoretoEmily DonatielloTina Landsvig BerentzenDario PitoccoFrancesco GiorginoPublished in: Diabetes, obesity & metabolism (2023)
, BW and other outcomes. This article is protected by copyright. All rights reserved.